Developer docs
API playgroundTry for free, no card

Search company profiles

Specialty Enzymes & Probiotics

Full company profile

uuid0008clw

Namestring
Specialty Enzymes & Probiotics
Legal namestring
Specialty Enzymes & Probiotics
Company typeenum
Private
Founded yearint
1957
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersChino, United States
HQ citystring
Chino
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
enzyme manufacturing, probiotic ingredients, nutraceutical enzymes, dietary supplement ingredients, spore-forming probiotics
Industry4 codes
1Probiotics (Strains, Spore-Formers, Synbiotic Components)
CodeAFAJAKAEPrimaryYes
2Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases)
CodeAFAJAJAEPrimaryNo
3Probiotics & Digestive Health Supplements
CodeCRADAGAFPrimaryNo
4Probiotics, Prebiotics & Postbiotics (Direct-Fed Microbials)
CodeAFADALAEPrimaryNo
NAICS code2 codes
  • Food Manufacturing311
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Food And Kindred Products2000
  • Miscellaneous Food Preparations & Kindred Products2090
Product category
Nutraceutical Enzyme and Probiotic Ingredients
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1B2B Ingredient Sales
TypeOne Time License
Description

Manufacturer and supplier of enzymes and probiotics sold as raw material ingredients to dietary supplement brands, food manufacturers, and formulation companies. Revenue generated through bulk ingredient sales, with customers using these materials to create finished supplement products.

specialtyenzymes.com
2Branded Product Formulas
TypeOne Time License
Description

Proprietary branded ingredient blends sold to manufacturers including probiotics (SEBiotic, ProbioSEB CSC3, SEBclausii, SEBtilis), digestive enzymes (DigeSEB line), systemic enzymes (Peptizyme SP, ImmunoSEB, SEBkinase), sports nutrition (Pepzyme AG, Prohydroxy P), and pet health (Exclzyme Pet, Bactase Oral Pet).

specialtyenzymes.com
3Custom Formulation Services
TypeProfessional Services
Description

Collaborative development of custom clean-label probiotic, prebiotic and enzyme blends tailored to specific customer requirements, providing differentiation and claim-rich formulations.

specialtyenzymes.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 13 records shown
1SEBiotic®
Description

Spore-forming probiotic (Bacillus coagulans LBSC) backed by 14 research studies supporting gut microbiota balance, IBS relief, immune modulation, and recovery from acute diarrhea.

specialtyenzymes.com
+12 more records
Core offering1 text field

Specialty Enzymes & Probiotics is a vertically integrated B2B manufacturer of nutraceutical enzymes and probiotics, producing branded ingredient blends and custom formulations for dietary supplement brands, pet nutrition companies, and food manufacturers. Founded in 1957 and headquartered in Chino, California, the company operates five global R&D centers and manufactures in NSF GMP, FSSC 22000, and ISO-17025 certified facilities. Its portfolio spans proteolytic, digestive, and systemic enzymes (including serrapeptase, papain, bromelain, nattokinase) and spore-forming Bacillus probiotic strains (B. coagulans, B. subtilis, B. clausii).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Exclzyme Pet clinical trial: 92% of dogs showed significant improvements in mobility and joint health; 52% reduction in lameness; 46% reduction in weight-bearing issues; 49% reduction in joint mobility issues; 56% reduction in pain; 58% increase in willingness to hold up contralateral limb
+5 more records
Product overview1 text field

Specialty Enzymes & Probiotics is a true manufacturer and global resource for quality enzymes and probiotics since 1957, offering a portfolio of branded products, custom formulations, and individual ingredients. Their branded portfolio includes probiotics (SEBiotic®, ProbioSEB CSC3®, SEBclausii™, SEBtilis™), digestive enzymes (DigeSEB Line, SEBGluten Relief™), systemic enzymes (Peptizyme SP®, ImmunoSEB), sports nutrition (DigeSEB Sport™, Pepzyme AG™, Prohydroxy P™), weight management (SlimSEB™), pet supplements (Exclzyme Pet™, Bactase Pet PB™, ProbioSEB CSC3 Pet™), and cleanse products (ClenzSEB™ Line). The company operates as a vertically integrated manufacturer controlling supply chain from fermentation through finished product, with five global R&D centers and over 900+ custom probiotic and enzyme formulas. Products are manufactured in NSF GMP-certified facilities with ISO 17025 testing and supported by clinical research published in peer-reviewed journals.

Product and service17 records
1SEBiotic®
CategoryProbiotic Ingredient
Description

Spore-forming probiotic (Bacillus coagulans LBSC) supported by 14 research studies for gut microbiota balance, IBS relief, immune modulation, and recovery from acute diarrhea and abdominal discomfort. Sold as a B2B ingredient to dietary supplement brands.

2ProbioSEB CSC3®
CategorySynbiotic Ingredient
Description

Three-strain spore-forming synbiotic combining Bacillus coagulans LBSC, Bacillus subtilis PLSSC, and Bacillus clausii 088AE with a prebiotic, demonstrating benefits across weight, metabolic, and cardiovascular markers in clinical study (8 lb weight decrease, 16% lower fasting insulin, 29% lower HOMA-IR).

3SEBclausii™
CategoryProbiotic Ingredient
Description

Spore-forming probiotic strain Bacillus clausii 088AE with FDA GRAS No Objection Letter, Health Canada NPN, and VHP listing for dogs — the only B. clausii strain with these regulatory distinctions. 98-100% viability across wide pH range; stable at up to 90°C for 1 hour; stable CFU counts over 30 months at room temperature.

4SEBtilis™
CategoryProbiotic Ingredient
Description

Spore-forming probiotic (Bacillus subtilis PLSSC) supporting healthy gut microbiota and inhibiting growth of pathogenic organisms, with FDA GRAS No Objection and Health Canada NPN.

5Peptizyme SP®
CategorySystemic Enzyme Ingredient
Description

Proteolytic enzyme (serrapeptase) isolated from Serratia microorganism, classified as a systemic enzyme absorbed from intestine into bloodstream, supporting fibrinolytic activity and healthy inflammatory response.

6ImmunoSEB
CategorySystemic Enzyme Ingredient
Description

Systemic enzyme complex studied in published peer-reviewed clinical trials and case series on COVID and post-viral fatigue, showing 93% clinical improvement and 91% fatigue resolution.

7DigeSEB™ Line
CategoryDigestive Enzyme Ingredient
Description

Line of digestive enzyme supplements formulated to maximize nutrient absorption from food, available in vegetarian formulations with or without probiotics.

8SEBGluten Relief™
CategoryDigestive Enzyme Ingredient
Description

Digestive enzyme supplement designed to support gluten sensitivity relief, part of the company's truly gluten-free enzyme solutions (less than 20 ppm gluten verified in growth media).

9DigeSEB Sport™
CategorySports Nutrition Ingredient
Description

Patent-pending synbiotic blend including proteolytic enzymes, five probiotics, and a prebiotic, supported by two published peer-reviewed clinical trials demonstrating support for protein digestion, amino acid absorption, and postbiotic production.

10Pepzyme AG™
CategorySports Nutrition Ingredient
Description

Proteolytic enzyme blend featured in peer-reviewed in vitro study demonstrating enhanced collagen breakdown and 30% improvement in DPP-IV inhibitory (anti-diabetic) activity supporting natural GLP-1 activity for the sports nutrition and metabolic health segments.

11Prohydroxy P™
CategorySports Nutrition Ingredient
Description

Digestive enzyme blend specially designed to help digest larger amounts of protein and improve nutrient absorption, particularly geared toward protein powder and meal replacement shake applications.

12SlimSEB™
CategoryWeight Management Ingredient
Description

Clinically studied weight management and metabolic health formula including patented SucroSEB enzyme that converts sugar to fiber. Clinical trial showed 8 lb body weight reduction, 6 cm waist reduction, 1.29-point HbA1c decrease, and 32 mg/dL total cholesterol reduction. Supports every stage of GLP-1 journey.

13Exclzyme Pet™
CategoryPet Supplement Ingredient
Description

Clinically studied systemic enzyme blend for pets shown to improve joint health in 92% of dogs in a randomized double-blind placebo-controlled trial (52% reduction in lameness, 46% reduction in weight-bearing issues, 49% reduction in joint mobility issues, 56% reduction in pain).

14Bactase Pet PB™
CategoryPet Supplement Ingredient
Description

Proprietary enzyme blend for companion animal oral health formulations, demonstrated in a 30-day randomized double-blind placebo-controlled trial to show 61-67% decrease in plaque, gingivitis, and bad breath in dogs.

15ProbioSEB CSC3 Pet™
CategoryPet Supplement Ingredient
Description

Three-strain spore-forming probiotic blend developed specifically for companion animals, combining Bacillus clausii 088AE, Bacillus coagulans LBSC, and Bacillus subtilis PLSSC to support gut health, immune function, and stool consistency.

16ClenzSEB™ Line
CategoryCleanse/Detox Ingredient
Description

Cleanse and detox product line supporting digestive health and wellness through enzyme-based formulations.

17Custom Formulation Services
CategoryCustom Formulation Service
Description

Collaborative development of custom clean-label probiotic, prebiotic, and enzyme blends tailored to specific customer requirements, providing differentiation and claim-rich formulations for B2B brand customers.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance11 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Specialty Enzymes & Probiotics

Nutraceutical Enzyme and Probiotic Ingredientsspecialtyenzymes.com

Specialty Enzymes & Probiotics firmographics

Firmographics
Name
Specialty Enzymes & Probiotics
Legal name
Specialty Enzymes & Probiotics
Website
https://specialtyenzymes.com
Company type
Private
Founded year
1957
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Specialty Enzymes & Probiotics industry classification

Industry
Product category
Nutraceutical Enzyme and Probiotic Ingredients
NAICS
Food Manufacturing (311), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)
akta.pro primary industry
Probiotics (Strains, Spore-Formers, Synbiotic Components) (AFAJAKAE)
akta.pro secondary industries
Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases) (AFAJAJAE), Probiotics & Digestive Health Supplements (CRADAGAF), Probiotics, Prebiotics & Postbiotics (Direct-Fed Microbials) (AFADALAE)

Keywords

  • Enzyme manufacturing
  • Probiotic ingredients
  • Nutraceutical enzymes
  • Dietary supplement ingredients
  • Spore-forming probiotics

Where Specialty Enzymes & Probiotics is headquartered

Location

Headquarters

HQ city
Chino
HQ country
United States
HQ region
North America

Markets served

Specialty Enzymes & Probiotics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. B2B Ingredient Sales: Manufacturer and supplier of enzymes and probiotics sold as raw material ingredients to dietary supplement brands, food manufacturers, and formulation companies. Revenue generated through bulk ingredient sales, with customers using these materials to create finished supplement products.
  2. Branded Product Formulas: Proprietary branded ingredient blends sold to manufacturers including probiotics (SEBiotic, ProbioSEB CSC3, SEBclausii, SEBtilis), digestive enzymes (DigeSEB line), systemic enzymes (Peptizyme SP, ImmunoSEB, SEBkinase), sports nutrition (Pepzyme AG, Prohydroxy P), and pet health (Exclzyme Pet, Bactase Oral Pet).
  3. Custom Formulation Services: Collaborative development of custom clean-label probiotic, prebiotic and enzyme blends tailored to specific customer requirements, providing differentiation and claim-rich formulations.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Specialty Enzymes & Probiotics product offering

Product offering

Core offering

Specialty Enzymes & Probiotics is a vertically integrated B2B manufacturer of nutraceutical enzymes and probiotics, producing branded ingredient blends and custom formulations for dietary supplement brands, pet nutrition companies, and food manufacturers. Founded in 1957 and headquartered in Chino, California, the company operates five global R&D centers and manufactures in NSF GMP, FSSC 22000, and ISO-17025 certified facilities. Its portfolio spans proteolytic, digestive, and systemic enzymes (including serrapeptase, papain, bromelain, nattokinase) and spore-forming Bacillus probiotic strains (B. coagulans, B. subtilis, B. clausii).

Product overview

Specialty Enzymes & Probiotics is a true manufacturer and global resource for quality enzymes and probiotics since 1957, offering a portfolio of branded products, custom formulations, and individual ingredients. Their branded portfolio includes probiotics (SEBiotic®, ProbioSEB CSC3®, SEBclausii™, SEBtilis™), digestive enzymes (DigeSEB Line, SEBGluten Relief™), systemic enzymes (Peptizyme SP®, ImmunoSEB), sports nutrition (DigeSEB Sport™, Pepzyme AG™, Prohydroxy P™), weight management (SlimSEB™), pet supplements (Exclzyme Pet™, Bactase Pet PB™, ProbioSEB CSC3 Pet™), and cleanse products (ClenzSEB™ Line). The company operates as a vertically integrated manufacturer controlling supply chain from fermentation through finished product, with five global R&D centers and over 900+ custom probiotic and enzyme formulas. Products are manufactured in NSF GMP-certified facilities with ISO 17025 testing and supported by clinical research published in peer-reviewed journals.

Differentiator

Problem solved

Functional benefit

Brands

  • SEBiotic®: Spore-forming probiotic (Bacillus coagulans LBSC) backed by 14 research studies supporting gut microbiota balance, IBS relief, immune modulation, and recovery from acute diarrhea.
  • ProbioSEB CSC3®
  • SEBclausii™
  • SEBtilis™
  • Exclzyme Pet™
  • Bactase Pet PB™
  • DigeSEB Sport™
  • SlimSEB™
  • Pepzyme AG™
  • Peptizyme SP®
  • ImmunoSEB®
  • DigeSEB™ Line
  • ProbioSEB CSC3 Pet™

Products and services

  • SEBiotic® Spore-forming probiotic (Bacillus coagulans LBSC) supported by 14 research studies for gut microbiota balance, IBS relief, immune modulation, and recovery from acute diarrhea and abdominal discomfort. Sold as a B2B ingredient to dietary supplement brands.
  • ProbioSEB CSC3® Three-strain spore-forming synbiotic combining Bacillus coagulans LBSC, Bacillus subtilis PLSSC, and Bacillus clausii 088AE with a prebiotic, demonstrating benefits across weight, metabolic, and cardiovascular markers in clinical study (8 lb weight decrease, 16% lower fasting insulin, 29% lower HOMA-IR).
  • SEBclausii™ Spore-forming probiotic strain Bacillus clausii 088AE with FDA GRAS No Objection Letter, Health Canada NPN, and VHP listing for dogs — the only B. clausii strain with these regulatory distinctions. 98-100% viability across wide pH range; stable at up to 90°C for 1 hour; stable CFU counts over 30 months at room temperature.
  • SEBtilis™ Spore-forming probiotic (Bacillus subtilis PLSSC) supporting healthy gut microbiota and inhibiting growth of pathogenic organisms, with FDA GRAS No Objection and Health Canada NPN.
  • Peptizyme SP® Proteolytic enzyme (serrapeptase) isolated from Serratia microorganism, classified as a systemic enzyme absorbed from intestine into bloodstream, supporting fibrinolytic activity and healthy inflammatory response.
  • ImmunoSEB Systemic enzyme complex studied in published peer-reviewed clinical trials and case series on COVID and post-viral fatigue, showing 93% clinical improvement and 91% fatigue resolution.
  • DigeSEB™ Line Line of digestive enzyme supplements formulated to maximize nutrient absorption from food, available in vegetarian formulations with or without probiotics.
  • SEBGluten Relief™ Digestive enzyme supplement designed to support gluten sensitivity relief, part of the company's truly gluten-free enzyme solutions (less than 20 ppm gluten verified in growth media).
  • DigeSEB Sport™ Patent-pending synbiotic blend including proteolytic enzymes, five probiotics, and a prebiotic, supported by two published peer-reviewed clinical trials demonstrating support for protein digestion, amino acid absorption, and postbiotic production.
  • Pepzyme AG™ Proteolytic enzyme blend featured in peer-reviewed in vitro study demonstrating enhanced collagen breakdown and 30% improvement in DPP-IV inhibitory (anti-diabetic) activity supporting natural GLP-1 activity for the sports nutrition and metabolic health segments.
  • Prohydroxy P™ Digestive enzyme blend specially designed to help digest larger amounts of protein and improve nutrient absorption, particularly geared toward protein powder and meal replacement shake applications.
  • SlimSEB™ Clinically studied weight management and metabolic health formula including patented SucroSEB enzyme that converts sugar to fiber. Clinical trial showed 8 lb body weight reduction, 6 cm waist reduction, 1.29-point HbA1c decrease, and 32 mg/dL total cholesterol reduction. Supports every stage of GLP-1 journey.
  • Exclzyme Pet™ Clinically studied systemic enzyme blend for pets shown to improve joint health in 92% of dogs in a randomized double-blind placebo-controlled trial (52% reduction in lameness, 46% reduction in weight-bearing issues, 49% reduction in joint mobility issues, 56% reduction in pain).
  • Bactase Pet PB™ Proprietary enzyme blend for companion animal oral health formulations, demonstrated in a 30-day randomized double-blind placebo-controlled trial to show 61-67% decrease in plaque, gingivitis, and bad breath in dogs.
  • ProbioSEB CSC3 Pet™ Three-strain spore-forming probiotic blend developed specifically for companion animals, combining Bacillus clausii 088AE, Bacillus coagulans LBSC, and Bacillus subtilis PLSSC to support gut health, immune function, and stool consistency.
  • ClenzSEB™ Line Cleanse and detox product line supporting digestive health and wellness through enzyme-based formulations.
  • Custom Formulation Services Collaborative development of custom clean-label probiotic, prebiotic, and enzyme blends tailored to specific customer requirements, providing differentiation and claim-rich formulations for B2B brand customers.

Quantifiable outcome

  • Exclzyme Pet clinical trial: 92% of dogs showed significant improvements in mobility and joint health; 52% reduction in lameness; 46% reduction in weight-bearing issues; 49% reduction in joint mobility issues; 56% reduction in pain; 58% increase in willingness to hold up contralateral limb
  • +5 more outcomes

Companies that use Specialty Enzymes & Probiotics

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Specialty Enzymes & Probiotics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Specialty Enzymes & Probiotics partnerships and signals

Strategic signal

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Specialty Enzymes & Probiotics competitors and assessment

Company assessment

Market position

Strengths4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Specialty Enzymes & Probiotics social profiles

Digital presence

Specialty Enzymes & Probiotics compliance and trust

Trust signal

Compliance11 records

Specialty Enzymes & Probiotics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Specialty Enzymes & Probiotics leadership team

Management profile

Number of profiles

Profiles1 record

Specialty Enzymes & Probiotics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Specialty Enzymes & Probiotics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Specialty Enzymes & Probiotics

What does Specialty Enzymes & Probiotics do?

Specialty Enzymes & Probiotics is a vertically integrated B2B manufacturer of nutraceutical enzymes and probiotics, producing branded ingredient blends and custom formulations for dietary supplement brands, pet nutrition companies, and food manufacturers. Founded in 1957 and headquartered in Chino, California, the company operates five global R&D centers and manufactures in NSF GMP, FSSC 22000, and ISO-17025 certified facilities. Its portfolio spans proteolytic, digestive, and systemic enzymes (including serrapeptase, papain, bromelain, nattokinase) and spore-forming Bacillus probiotic strains (B. coagulans, B. subtilis, B. clausii).

Is Specialty Enzymes & Probiotics a public or private company?

Specialty Enzymes & Probiotics is a private company. It is classified as family owned and is currently operating.

When was Specialty Enzymes & Probiotics founded?

Specialty Enzymes & Probiotics was founded in 1957. It employs 11 to 50 people.

Where is Specialty Enzymes & Probiotics based?

Specialty Enzymes & Probiotics is headquartered in Chino, United States, in the North America region.

How does Specialty Enzymes & Probiotics make money?

Three revenue lines are on record. B2B Ingredient Sales are the primary driver. The others are branded Product Formulas and custom Formulation Services.

Does Specialty Enzymes & Probiotics have an API?

No public API is recorded for Specialty Enzymes & Probiotics.

What industry is Specialty Enzymes & Probiotics in?

Specialty Enzymes & Probiotics's product category is Nutraceutical Enzyme and Probiotic Ingredients. Its primary akta.pro industry code is AFAJAKAE, Probiotics (Strains, Spore-Formers, Synbiotic Components), with a secondary code of AFAJAJAE, Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases). Its NAICS code is 311 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireBreakthrough Research Demonstrates SlimSEB™ Delivers Smarter Glucose SupportA study of SlimSEB™, a new ingredient from Specialty Enzymes & Probiotics, showed it reduces sugar availability and moderates post-meal glucose response. In a clinical trial, supplementation cut AUC by 16.90%, and in vitro analysis found a 34% reduction in simple sugar release. The results support its use for glucose support.AijournSpecialty Enzymes & Probiotics Launches SlimSEB™Specialty Enzymes & Probiotics launched SlimSEB, a multi-action blend of enzymes, probiotics, and herbal extracts for weight management and cardiometabolic support. The product is backed by 10 gold-standard clinical trials showing support for weight reduction, healthy cholesterol, and lower HbA1c. It is intended for standalone and GLP-companion formulations.PR NewswireSpecialty Enzymes & Probiotics Launches SlimSEB™Specialty Enzymes & Probiotics has launched SlimSEB™, a multi-action blend of enzymes, probiotics, and herbal extracts designed for cardiometabolic wellness and weight management. The ingredient is supported by ten clinical trials demonstrating benefits in weight reduction, cholesterol levels, and HbA1c control. It is positioned as a research-backed solution for formulators seeking clean-label options for metabolic health products.Third NewsNew Clinical Trial Highlights the Benefits of Exclzyme Pet™ for Joint Health in DogsA recent double-blind clinical trial conducted by Specialty Enzymes & Probiotics found that 92% of canine participants showed significant improvements in mobility and joint health after using Exclzyme Pet™, a systemic enzyme supplement designed for pets. The study measured reductions in pain, stiffness, and lameness alongside enhanced flexibility and activity levels. The company, which has over 45 years of experience in pet nutrition, emphasized the breakthrough implications for the pet supplement industry.PR NewswireBreakthrough Study Shows Exclzyme Pet™ Supports Joint Health in 92% of DogsSpecialty Enzymes & Probiotics announced results from a double-blind clinical trial showing their Exclzyme Pet™ supplement improved joint health and mobility in 92% of participating dogs. The gold-standard study evaluated pain scores, degree of lameness, and radiological assessments, demonstrating reductions in pain and stiffness along with enhanced joint flexibility and activity levels. The company positioned the findings as a significant advancement in evidence-based pet nutrition for aging and active dogs struggling with joint discomfort.PR NewswireBacillus clausii 088AE Becomes the First VHP-Listed B. clausii for DogsSpecialty Enzymes & Probiotics announced that its Bacillus clausii 088AE spore-forming probiotic strain has been added to Health Canada's Veterinary Health Product list for dogs, making it the first and only B. clausii strain to achieve this regulatory distinction. The VHP review process required precise strain identification, documented safety, manufacturing consistency, and substantiated claims, which the strain met in full, setting a new benchmark for spore-forming probiotics in companion animal health. The VHP listing provides pet supplement brands with regulatory credibility for retailers, veterinarians, and ingredient-conscious pet parents seeking science-backed formulations.PR NewswireNew Clinical Trial Published on Specialty Enzymes & Probiotics' Bactase Pet PB™Specialty Enzymes & Probiotics announced publication of a clinical study demonstrating the oral health benefits of Bactase Pet PB™, a proprietary enzyme blend for companion animal oral health formulations. In a 30-day randomized, double-blind, placebo-controlled trial, dogs receiving twice-daily Bactase Pet PB™ showed a 61-67% decrease in plaque, gingivitis, and bad breath compared to the placebo group. The company highlighted that conducting double-blind, placebo-controlled trials in dogs is scientifically rigorous and expensive, positioning the clinical evidence as a differentiating factor for formulators seeking reliable scientific data for pet oral health products.SupplysidesjWeight management rewired: Formulation in the GLP-1 eraA sponsored webinar is being announced to address the nutritional support needs of GLP-1 medication users, featuring experts from Gateway Health Alliances, Specialty Enzymes & Probiotics, and TSI Group. The event will cover formulation strategies for dietary supplements targeting muscle preservation, gut health, and metabolic function in this user population. The rise of GLP-1 weight loss medications is creating new demand for science-backed nutritional products that address common side effects and nutritional gaps.PR NewswirePepzyme AG™ Supercharges Collagen Breakdown for GLP-1 SupportSpecialty Enzymes & Probiotics announced that its Pepzyme AG™ proteolytic enzyme blend, featured in a peer-reviewed in vitro study using the INFOGEST digestion model, demonstrated enhanced collagen breakdown and increased release of low-molecular-weight bioactive peptides. The study found the released peptides showed more than 30% improvement in anti-diabetic (DPP-IV inhibitory) activity, supporting natural GLP-1 activity to complement GLP-1 therapies. With GLP-1 use projected to reach 30 million Americans by 2030, the company is positioning the product as a scientific differentiation tool for collagen brands in the metabolic health market.PR NewswireNew Study Shows DigeSEB Super™ Enhances DigestionSpecialty Enzymes & Probiotics reported that its digestive enzyme blend, DigeSEB Super™, reduced food viscosity by approximately 82% and boosted amino acid release by over 50% in a recent study. The research utilized static and modified semi-dynamic models to evaluate the supplement's efficacy in enhancing macronutrient digestion. CEO Vic Rathi stated the findings demonstrate the product's potential to alleviate gastrointestinal discomfort.